Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Insulet reported $1.47B in Current Assets for its fiscal quarter ending in September of 2023.

Current Assets Change Date
Align Technology USD 2.7B 236.35M Sep/2023
AtriCure USD 252.72M 14.74M Sep/2023
Avanos Medical USD 524.6M 17.7M Sep/2023
Baxter International USD 12.03B 3.83B Sep/2023
Becton, Dickinson and Co. USD 8.68B 88M Sep/2023
Cardinal Health USD 34.69B 855M Sep/2023
Cooper Companies USD 1.7B 6.1M Sep/2023
Dexcom USD 4.7B 304.5M Sep/2023
Edwards Lifesciences USD 4.07B 420.5M Sep/2023
Eli Lilly USD 23.01B 1.68B Sep/2023
Globus Medical USD 1.92B 707.33M Sep/2023
ICU Medical USD 1.22B 25.33M Sep/2023
Inogen USD 225.27M 43.96M Sep/2023
Insulet USD 1.47B 49.6M Sep/2023
Integra LifeSciences USD 1.03B 24.03M Sep/2023
Masimo USD 1.24B 29.3M Sep/2023
Merit Medical Systems USD 585.32M 9.59M Sep/2023
Roche Holding CHF 30.98B 2.84B Jun/2023
Sientra USD 86.51M 5.4M Sep/2023
Stryker USD 11.04B 894M Sep/2023
Tandem Diabetes Care USD 758.14M 6.16M Sep/2023
Teleflex USD 2.1B 651.47M Sep/2023
West Pharmaceutical Services USD 1.97B 98.1M Sep/2023
Zimmer Biomet Holdings USD 4.37B 15.9M Sep/2023